ArticleCase reports in transplantation2025
Hepatitis E Virus Infection in a Liver Transplant Recipient Presenting With Late-Onset Acute Rejection and Treated With Ribavirin.
Article in Case reports in transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis E virus (HEV) is increasingly recognized as a cause of allograft hepatitis in transplant recipients. Persistent HEV infection is often asymptomatic with nonspecific findings on liver biopsy, requiring high clinical awareness to order viral testing. We present a challenging case of HEV allograft hepatitis that presented with increasing liver enzymes and subtle biopsy findings of hepatocyte apoptosis and mitosis, diagnosed 1 month after treatment of acute rejection. Viral testing was positive for HEV IgM and HEV RNA, consistent with acute HEV infection. The patient was treated with a 12-week course of ribavirin. Based on this index case, we reviewed whether liver allograft biopsies with apoptosis were associated with viral detection at our institution during a 6-year period (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.